Global Drugs For Benign Prostatic Hypertrophy Market 2019 - PowerPoint PPT Presentation

About This Presentation
Title:

Global Drugs For Benign Prostatic Hypertrophy Market 2019

Description:

A report from TheBusinessResearchCompany shows that the "Global Drugs For Benign Prostatic Hypertrophy Market 2019" is expected to grow to $5.65 billion at a CAGR of 8.8% through 2022. Read more at – PowerPoint PPT presentation

Number of Views:26

less

Transcript and Presenter's Notes

Title: Global Drugs For Benign Prostatic Hypertrophy Market 2019


1
Global Drugs For Benign Prostatic Hypertrophy
Market Size, Forecast, Share, Growth Trends
2019 - 2022
Drugs For Benign Prostatic Hypertrophy Global
Market Report 2019
2
  • The drugs for benign prostatic hypertrophy market
    consists of sales of benign prostatic hypertrophy
    drugs to treat enlarged prostate glands. Benign
    Prostatic Hypertrophy is commonly seen in men
    older than age 50.
  • The global drugs for benign prostatic hypertrophy
    market was valued at about 4.03 billion in 2018
    and is expected to grow to 5.65 billion at a
    CAGR of 8.8 through 2022.
  • The regions covered are Asia-Pacific, Western
    Europe, Eastern Europe, North America, South
    America, Middle East, and Africa.

Drugs For Benign Prostatic Hypertrophy Global
Market Report 2019
3
List of Tables
Table 1 Global Historic Market Growth,
2014-2018, Billion Table 2 Global Forecast
Market Growth, 2014-2022F, 2025F, 2030F,
Billion Table 3 Global Drugs for Benign
Prostatic Hypertrophy Market, Segmentation By
Type, Historic and Forecast, 2014-2018, 2022F,
2025F, 2030F, Billion Table 4 Global Drugs for
Benign Prostatic Hypertrophy Market, Segmentation
By End User, Historic and Forecast, 2014-2018,
2022F, 2025F, 2030F, Billion Table 5 Global
Drugs for Benign Prostatic Hypertrophy Market,
Split By Region, Historic and Forecast,
2014-2018, 2022F, 2025F, 2030F,
Billion . . Table 45 Allergan PLC Financial
Performance Table 46 Astellas Pharma Inc.
Financial Performance Table 47 Boehringer
Ingelheim Financial Performance Table 48 Eli
Lilly and Company Financial Performance Table 49
GlaxoSmithKline PLC Financial Performance
4
  • Companies Mentioned
  • Allergan PLC, Astellas Pharma Inc., Boehringer
    Ingelheim, Eli Lilly and Company, GlaxoSmithKline
    PLC.
  • Segments
  • By Type
  • By Geography

Request a Sample copy of this report
5
Europe The Business Research Company 47
Anchorage Point, 42 Cuba Street, Canary Wharf,
London, England, E14 8NE. 44 207 1930
708 Email info_at_tbrc.info www.tbrc.info
Asia The Business Research Company, Horizon
Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara
Hills Hyderabad (India) 500033 91
8897263534 Email info_at_tbrc.info www.tbrc.info
Americas The Business Research Company 625 South
Avenue, Apt B204, Secane, Philadelphia, PA 19018,
USA 1 3156230293 Email info_at_tbrc.info www.tbrc.
info
Follow us on our social media and message us!
Write a Comment
User Comments (0)
About PowerShow.com